Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Olema Pharmaceuticals Inc shares valued at $1,727,370 were purchased by Bain Capital Life Sciences Inv on Jan 08 ’25. At $5.76 per share, Bain Capital Life Sciences Inv acquired 300,000 shares. The insider’s holdings grew to 7,800,000 shares worth approximately $48.44 million following the completion of this transaction.
Also, Graham G. Walmsley sold 700,761 shares, netting a total of over 4,730,137 in proceeds. Following the sale of shares at $6.75 each, the insider now holds 0 shares.
Before that, Logos Opportunities Fund I LP had added 700,761 shares to its account. In a trade valued at $4,730,137, the Affiliate bought Olema Pharmaceuticals Inc shares for $6.75 each.
As published in their initiating research note from Goldman on April 02, 2024, Olema Pharmaceuticals Inc [OLMA] has been a Buy and the price target has been revised to $24. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in late January. As of July 21, 2023, Oppenheimer has initiated its “an Outperform” rating for OLMA. Earlier on May 05, 2023, CapitalOne initiated its rating. Their recommendation was “an Overweight” for OLMA stock.
Analyzing OLMA Stock Performance
During the last five days, there has been a surge of approximately 9.33%. Over the course of the year, Olema Pharmaceuticals Inc shares have jumped approximately 6.52%. Shares of the company reached a 52-week high of $6.46 on 01/27/25 and a 52-week low of $4.60 on 01/13/25. A 50-day SMA is recorded $7.20, while a 200-day SMA reached $10.71. Nevertheless, trading volume fell to 1.82 million shares from 1.79 million shares the previous day.
Support And Resistance Levels for Olema Pharmaceuticals Inc (OLMA)
According to the 24-hour chart, there is a support level at 5.85, which, if violated, would cause prices to drop to 5.50. In the upper region, resistance lies at 6.43. The next price resistance is at 6.66. RSI (Relative Strength Index) is 50.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.52, which suggests the price will decrease in the coming days. Percent R is at 13.44%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
